Duo’s patented drug chemistry platform assembles potent molecules into nanomedicine complexes that bypass healthy organs and penetrate hard-to-treat tumors, such as those found in patients with pancreatic cancer. Lead product, DUO-207, has completed GLP tox and is ready to begin clinical testin.